{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:42:59Z","timestamp":1774435379499,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.nmd.2020.03.012","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T01:54:51Z","timestamp":1586742891000},"page":"534-538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review"],"prefix":"10.1016","volume":"30","author":[{"given":"Yaru","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.03.012_bib0001","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fneur.2018.00077","article-title":"Clinical characteristics of juvenile myasthenia gravis in southern china","volume":"9","author":"Huang","year":"2018","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2020.03.012_bib0002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto\u2013antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.nmd.2020.03.012_bib0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.nmd.2015.03.014","article-title":"Selective response to rituximab in a young child with MuSK\u2013associated myasthenia gravis","volume":"25","author":"Govindarajan","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.nmd.2020.03.012_bib0004","first-page":"80","article-title":"Three AChR\u2013Ab and MuSK\u2013Ab double\u2013seropositive myasthenia gravis patients and review of literature","volume":"25","author":"Yanlei","year":"2018","journal-title":"Chin J Neuroimmunol Neuro"},{"issue":"8","key":"10.1016\/j.nmd.2020.03.012_bib0005","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/01.wnl.0000267694.45244.f4","article-title":"Anti\u2013musk antibody after thymectomy in a previously seropositive myasthenic child","volume":"69","author":"Saulat","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.nmd.2020.03.012_bib0006","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1007\/s00415-009-5215-2","article-title":"Juvenile seropositive myasthenia gravis with anti\u2013MuSK antibody after thymectomy","volume":"256","author":"Kostera\u2013Pruszczyk","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2020.03.012_bib0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","article-title":"MuSK\u2013antibody positive myasthenia gravis: questions from the clinic","volume":"201\u2013202","author":"Sanders","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"12","key":"10.1016\/j.nmd.2020.03.012_bib0008","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00415-012-6661-9","article-title":"Clinically biphasic myasthenia gravis with both ACHR and MuSK antibodies","volume":"259","author":"Rajakulendran","year":"2012","journal-title":"J Neurol"},{"issue":"11","key":"10.1016\/j.nmd.2020.03.012_bib0009","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.nmd.2013.07.010","article-title":"Muscle specific kinase autoimmune myasthenia gravis in children: a case series","volume":"23","author":"Skjei","year":"2013","journal-title":"Neuromuscul Disord"},{"issue":"22","key":"10.1016\/j.nmd.2020.03.012_bib0010","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti\u2013agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.03.012_bib0011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clineuro.2018.06.041","article-title":"Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients","volume":"172","author":"Li","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"10.1016\/j.nmd.2020.03.012_bib0012","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti\u2013MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.nmd.2020.03.012_bib0013","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.braindev.2011.12.014","article-title":"Childhood\u2013onset anti\u2013MuSK antibody positive myasthenia gravis demonstrates a distinct clinical course","volume":"34","author":"Takahashi","year":"2012","journal-title":"Brain Dev"},{"issue":"3","key":"10.1016\/j.nmd.2020.03.012_bib0014","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK\u2013antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2020.03.012_bib0015","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4103\/0028-3886.68687","article-title":"Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient","volume":"58","author":"Suhail","year":"2010","journal-title":"Neurol India"},{"issue":"7","key":"10.1016\/j.nmd.2020.03.012_bib0016","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.nmd.2016.04.008","article-title":"Anti\u2013MuSK myasthenia gravis with prolonged remission","volume":"26","author":"Bouwyn","year":"2016","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:19Z","timestamp":1760774959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620300857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0960896620300857"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.03.012","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AChR myasthenia gravis switching to MuSK or double antibody positive myasthenia gravis in two children and literature review","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}